ArticleScientific reports2026
Yeast prebiotics mitigate lead toxicity in Nile tilapia through physiological and ultrastructural improvements.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- DietaryFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lead (Pb) contamination is a major threat to aquaculture and food safety, mainly due to its hepatotoxic and oxidative impacts on fish. This study evaluated the ameliorative role of yeast-derived prebiotics, mannan oligosaccharides (MOS) and β-glucan (βG), against Pb-induced toxicity in Nile tilapia (Oreochromis niloticus). A total of 180 fish were allocated into four treatment groups for eight weeks: control, MOS/βG-supplemented diet (0.3%), Pb exposure (10 mg/L), and combined Pb with MOS/βG supplementation. Pb exposure significantly reduced serum total protein, albumin, and globulin while increasing hepatic enzymes, indicating liver dysfunction. Severe hepatic necrosis, hepatopancreatic degeneration, gill lamellar fusion, and mitochondrial disruption were also observed, alongside elevated Pb residues in liver > gills > muscles. Dietary MOS/βG markedly restored altered biochemical markers, improved histoarchitectural and ultrastructural integrity, and reduced Pb accumulation in all tissues compared with Pb-exposed fish (p < 0.05). These findings demonstrate that MOS/βG supplementation enhances physiological resilience to heavy metal stress and is associated with reduced Pb bioaccumulation, highlighting their potential as a sustainable nutritional intervention to protect fish health and reduce tissue contamination in Pb-polluted aquaculture environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.